Dudediligence.

Maze Therapeutics, Inc

MAZENASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Aug 178-KOfficer or director change and Regulation FD disclosure5.027.019.01
  2. Aug 1110-QQuarterly report
  3. Aug 118-KResults of operations2.029.01
  4. Jul 2913GPassive stake of 5% or more (13G), filed by BlackRock
  5. Jun 108-KShareholder vote5.07
  6. May 228-KOfficer or director change5.02
  7. May 1210-QQuarterly report
  8. May 128-KResults of operations2.029.01
  9. Apr 228-KOther events8.019.01
  10. Apr 22424B5Prospectus for an offering
  11. Mar 2510-KAnnual report
  12. Mar 258-KResults of operations and officer or director change2.025.027.019.01
  13. Feb 48-KMaterial agreement and end of a material agreement1.011.022.03
  14. Nov 6, 202510-QQuarterly report
  15. Nov 6, 20258-KResults of operations2.029.01
  16. Nov 6, 2025424B3Prospectus for an offering
  17. Oct 17, 2025S-1Registration of new shares
  18. Oct 6, 20258-KOfficer or director change5.02
  19. Sep 11, 20258-KMaterial agreement and unregistered sale of shares1.013.027.019.01
  20. Sep 2, 20258-KOfficer or director change5.02
  21. Aug 12, 202510-QQuarterly report
  22. Aug 12, 20258-KResults of operations2.029.01
  23. May 14, 202510-QQuarterly report
  24. May 14, 20258-KResults of operations2.029.01
  25. Mar 31, 202510-KAnnual report
  26. Mar 31, 20258-KResults of operations2.029.01
  27. Jan 31, 2025424B4Prospectus for an offering